View
218
Download
0
Category
Tags:
Preview:
DESCRIPTION
Blueocean Market Intelligence conducts market opportunity assessment cases study for Opioids covering more than 10 countries. The case study includes regulatory scenario assessment, market forecast and identification of potential partners in the Opioids space.
Citation preview
© Copyright
An Illustrative case study
Market Overview of Opioids
© 2014 blueocean market intelligence
Project Objective & Methodology
2
© 2014 blueocean market intelligence
Content
An Overview: International Conventions and Guidelines
3
© 2014 blueocean market intelligence
Regulatory Heat Map (Focus Regions)
Country Summary
4
Country rank ordering
framework
Simple: Pathways are rational/High degree of overall acceptance/Low operational barrier
Complex: Pathways are not well defined/Low degree of overall acceptance/High operational barrier
*Based on quantitative matrix
© 2014 blueocean market intelligence
Content
5
© 2014 blueocean market intelligence
Methodology – Current and Future Market Sizing
6
© 2014 blueocean market intelligence
Consumption Patterns - Country 1
7
Historical Data Analysis - 2010
© 2014 blueocean market intelligence
Methodology – Current and Future Market Sizing
8
© 2014 blueocean market intelligence
Consumption Patterns - Country 1
Consumption Patterns - Country 1
9
Historical Data Analysis - 2012
Forecasted Data Analysis - 2023
© 2014 blueocean market intelligence
Focus Geography Snapshot in 2010 & 2012
Focus Geography Snapshot Estimated in 2023
10
Reported and Estimated Opioid Revenues and Volumes in each Geography
Forecasted Opioid Revenues and Volumes in each Geography
© 2014 blueocean market intelligence
Content
Country Prioritization for Focus Geographies
11
© 2014 blueocean market intelligence
Regulatory Intelligence (1/2)
Regulatory Intelligence (2/2)
12
Opioid are recognized for pain management in Country 1
Narcotic guidelines are well established in Country 1 being a member of Single Convention
© 2014 blueocean market intelligence
Hurdles around Opioid usage in Pain Management
Activities to Rationalize the Opioid Usage
13
Average clinical decision making standard for pain management is observed in Country 1
© 2014 blueocean market intelligence
Content
14
© 2014 blueocean market intelligence
Methodology for Screening of Potential Partners
15
© 2014 blueocean market intelligence
Prioritization of Potential Companies for Partnership
Top Brands - Global
16
© 2014 blueocean market intelligence
Key Brands (Country – C1)
17
© 2014 blueocean market intelligence
Content
Preferred Category and Brands of Opioids
18
Convergence in usage of Morphine, Fentanyl and Oxycodone for pain management is seen between INCB and PMR data
© 2014 blueocean market intelligence
Availability and Accessibility of OBA
Conditions for Opioid Prescription
19
Convergence in the type of hurdles in OBA usage is seen between secondary research and PMR data
OBA are prescribed for both malignant and non-malignant pain types in Country 1
© 2014 blueocean market intelligence
New Developments in Narcotics Drugs Space
20
© 2014 blueocean market intelligence
Content
Abbreviations / Acronyms
21
Proprietary and Confidential
For further information, please contact: Suchitra Eswaran Vice President – Life Sciences suchitra.e@blueoceanmi.com
Seattle |Chicago | Cincinnati | Bangalore | Dubai www.blueoceanmi.com
Recommended